Fidson Healthcare Plc

What Fidson Healthcare Plc does

Fidson Healthcare manufactures branded generic pharmaceutical products across a wide range of therapeutic categories. Products are distributed to hospitals, clinics, pharmacies, and wholesale distributors across Nigeria. The manufacturing plant includes solid dose (tablets and capsules), liquid (syrups and suspensions), and topical (creams and ointments) production capabilities. Fidson also provides contract pharmaceutical manufacturing services to third-party clients. Raw materials — active pharmaceutical ingredients (APIs) and excipients — are primarily imported, making the business sensitive to foreign exchange availability and global API supply dynamics.

Risks to understand before buying shares

• Foreign exchange risk: Fidson imports a significant share of its active pharmaceutical ingredients and excipients. Naira depreciation increases input costs and can compress margins or require price increases that affect sales volumes.
• Regulatory risk: NAFDAC product registration, manufacturing site inspections, and importation policies directly affect which products Fidson can sell and manufacture. Adverse regulatory actions could disrupt supply.
• Raw material supply risk: global API supply chain disruptions — including from major manufacturing countries — can affect Fidson's ability to maintain production volumes across its product lines.
• Competition: generic pharmaceutical markets are price-competitive. Imported generics and other domestic manufacturers compete on price and availability, particularly in the retail pharmacy channel.
• The value of shares can rise or fall. Past performance of FIDSON is not a guide to future returns.